Issue link: http://deals.uberflip.com/i/1489093
Full-Service Independent Compounding Pharmacy Located in West US #65780 Sign NDA ► 2022 Revenue Est. $ 2.0MM 2022 EBITDA Est. $ 440K+ DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generational Equity of this document. At all times Generational Equity and its affiliate network members is an agent for the seller and not for the buyer. Generational Equity's fees are paid by the seller. Ryan Johnson Managing Director Email: rjohnson@generational.com Office/Fax: 972-232-1132 Generational Equity, LLC 3400 North Central Expressway, Suite 100 Richardson, TX 75080 www.Generational.com I www.DealForce.com BUSINESS HIGHLIGHTS The Company is an independently owned, full-service compounding pharmacy that provides custom prescribed medications for human and animal patients. It provides hazardous and non-hazardous non-sterile compounding, as well as hazardous and non-hazardous sterile compounding. All compounds require a valid prescription from their prescriber, which includes doctors, dentists, naturopaths, nurse practitioners, physician assistants, and veterinarians. The Company does not accept insurance and requests prepayment for products from all new customers. INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 COMPANY STATS • 16+ years of operations • 2,765-square foot retail facility • 7,000 active accounts • 10 full-time, 2 part-time employees INVESTMENT APPEAL • Diversified Customer Base - The Company serves thousands of patients and prescriber offices. No one customer accounts for a material percentage of annual revenues, and the loss of any one customer would not have a significant impact on revenues and profitability. • Product Offering - The Company maintains an extensive inventory of master compounding formulas (over 3,300) that are continually improved and expanded upon. • Expandable - The efficient, organized operations and nimble approach to meeting market needs is ideal for replication into other geographies. • Recession-Resistant Industry - As consumers continue to require compounded prescriptions to address a variety of ailments, provide alternative routes of drug administration as well as dosages or strengths that are otherwise not commercially available, the industry will experience stable need-based demand. GROWTH OPPORTUNITIES • Local Market Unawareness • Health Plan Payment Relationships • Geographic Expansion • Product/Service Expansion & Support Customer Markets Revenue Performance Revenue Mix